Biography
Dr. Robert Kratzke is an Associate Professor of Medicine at the University of Minnesota Masonic Cancer Center in Minneapolis. He specializes in thoracic oncology with a particular focus on the molecular biology of mesothelioma. Dr. Kratzke trained at the NCI-Navy Medical Oncology Branch and has dedicated his career to understanding the molecular abnormalities that drive mesothelioma, including research into gene replacement therapy and epigenetic mechanisms. His work bridges laboratory research and clinical care, offering patients at Masonic Cancer Center access to cutting-edge molecular approaches to mesothelioma treatment.
Education & Training
- Medical Degree — University of Minnesota Medical School (Medicine)
- Residency — National Naval Medical Center (Internal Medicine)
- Fellowship — National Cancer Institute — Navy Medical Oncology Branch (Medical Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
- Molecular Oncology
As a medical oncologist, Dr. Robert Kratzke focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
Research Focus
Molecular abnormalities in mesothelioma, gene replacement therapy for thoracic malignancies, and epigenetic mechanisms in mesothelioma tumorigenesis.
Treatment Center
Dr. Robert Kratzke practices at Masonic Cancer Center in Minneapolis, MN.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
What is Dr. Kratzke's research focus in mesothelioma?
Dr. Kratzke studies the molecular abnormalities that drive mesothelioma, including gene replacement therapy and epigenetic mechanisms. His goal is to identify new therapeutic targets that can improve treatment outcomes.